Analysis of occurrences and causes of abnormal liver function in 109 patients with COVID-19.

CONTEXT

COVID-19 is a novel coronavirus pneumonia, which is related to abnormal liver function. Thus, it is important to explore the occurrences and causes of abnormal liver function with COVID-19.

METHODS

We chose 109 patients with COVID-19 in 2020 and studied the relationship between gender, age, basic diseases, antiviral drug treatment, disease classification, and abnormal liver function, and analyzed the causes of abnormal liver function in patients with COVID-19.

RESULTS

Among patients, 46 (42.20%) had abnormal liver function at admission; 37 (80.43%) had mild abnormal liver function; and 9 (19.57%) had severe liver function. Compared with other age groups, the abnormal rate of serum ALP in the group younger than 21 years old were the highest ( < 0.05). The abnormal rates and concentrations of serum ALT, AST and γ-GT in the male groups were higher than in female groups ( < 0.05), basic disease group were higher than those in the non-basic disease group ( < 0.05). Serum γ-GT concentration after 1 week of antiviral treatment was higher than that before treatment ( < 0.05). The abnormal rate of ALT and AST at discharge was lower than that after antiviral treatment for 1 week ( < 0.05). Serum TB and AST concentrations at discharge were lower than those before treatment ( < 0.05). Serum AST and γ-GT concentrations in severe/critical type group were higher than those in mild or ordinary type group ( < 0.05).

CONCLUSIONS

In this study, we found male sex, basic diseases, antiviral drugs, and severe/critical types are related to the occurrence of abnormal liver function in COVID-19 patients.